Elevated PART1 functions as a CeRNA and binds competitively to miR-129, which has been found to act as a tumor suppressor miR in ESCC, resulting in increased expression of the anti-apoptotic protein Bcl-2 [73]. The gene discussed is PART1; the disease is esophageal squamous cell carcinoma.